BACKGROUND: The coagulant activity of factor VII increases with age and is
a risk factor in middle aged subjects. Its role in elderly people is still
unknown. The aim of this study was to evaluate whether or not FVIIc is a ri
sk factor in such population,
PATIENTS AND METHOD: Study design: cases and controls study. The group of c
ases consisted of 79 subjects fulfilling the following criteria: a) age bet
ween 65 and 85 years, and b) admission in the Valle de las Pedroches Hospit
al of Pozoblanco (Cordoba, Spain) due to a myocardial infarction and/or uns
table angina, 2 or 6 months before their enrollment. The control group cons
isted of 81 subjects of similar age, chosen at random from the municipal re
gistry, and excluding those with coronary heart disease. Factor Vile was me
asured by conventional methods. Plasma samples were diluted with deficient
plasma in FVIIc, and coagulation times were measured after adding thrombopl
astin and calcium. The measures were compared with a "control", plasma and
the results were presented as a percentage.
RESULTS: There were no significant differences in the FVIIc between cases (
118.3 [SD 22.2]) and controls (116.5 [24.4]; p = 0.630) in the total group,
When classified according to their age, it was observed that within the gr
oup of more than 75 years old, cases had a higher FVIIc than controls (124.
1 [18.2] vs 113.3 [23.5]; p < 0.05). When the classification was carried ou
t according to sex, male presented similar results than the total group, Bi
variable analysis showed, in subjects with coronary diseases, that FVIIc wa
s related to total cholesterol, cLDL, apoprotein a, body mass index, HbA(1c
), and age. Factors related to FVIIc in the multivariable analysis were bas
al glucose serum level, body mass index; cHDL was negatively related.
CONCLUSIONS: FVIIc is higher in very old subjects with coronary diseases so
it may be a significant coronary risk factor in this age group.